AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 48 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.97 and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,268 | -61.2% | 3,744 | -58.7% | 0.00% | – |
Q3 2022 | $11,000 | – | 9,068 | +2085.1% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 415 | -49.9% | 0.00% | – |
Q1 2022 | $2,000 | -75.0% | 829 | -57.7% | 0.00% | – |
Q4 2021 | $8,000 | -81.8% | 1,959 | -80.4% | 0.00% | – |
Q3 2021 | $44,000 | -21.4% | 10,000 | -28.9% | 0.00% | – |
Q2 2021 | $56,000 | -24.3% | 14,060 | -0.8% | 0.00% | – |
Q1 2021 | $74,000 | -42.2% | 14,174 | -40.4% | 0.00% | – |
Q4 2020 | $128,000 | +88.2% | 23,769 | +68.6% | 0.00% | – |
Q3 2020 | $68,000 | -63.2% | 14,100 | -63.0% | 0.00% | – |
Q2 2020 | $185,000 | +340.5% | 38,081 | +98.5% | 0.00% | – |
Q1 2020 | $42,000 | -27.6% | 19,188 | +91.9% | 0.00% | – |
Q4 2019 | $58,000 | +81.2% | 10,000 | 0.0% | 0.00% | – |
Q3 2019 | $32,000 | -23.8% | 10,000 | 0.0% | 0.00% | – |
Q2 2019 | $42,000 | -54.3% | 10,000 | -24.9% | 0.00% | – |
Q1 2019 | $92,000 | +300.0% | 13,322 | +905.4% | 0.00% | – |
Q3 2018 | $23,000 | – | 1,325 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |